The Future of Oligos in Asia: Explained

Integrating Machine Learning in CMC Development of Antibody Modalities

«Если хочешь увидеть будущее, поезжай в Китай».

Revolutionizing Cell Therapy with Automated Manufacturing and Testing Solutions

Switzerland’s $2BN Tunnel U-Turn

De-dollarisation is just a fashionable debate. Every global crisis sends world back to dollar

DUBLET LEWEGO! SIEDEM GOLI BARÇY! BARCELONA - NEWCASTLE, SKRÓT MECZU

Leveraging Gene Editing Technologies for Precision and Efficiency in Cell & Gene Therapy Development

What is Israel's primary goal in the Iran war? | 7.30

I Ditched OpenClaw For Perplexity Computer … It’s WILD!

Leveraging Inherent Proximity to Develop Novel Bispecific ADCs

Iran attacks on Gulf energy sites send oil, gas prices soaring | East Asia Tonight (Mar 19)

Inside the secret hotel escape of Iran’s footballers in Australia | BBC News

Third Webinar | Par 2 – Presentation #2 | 2026 Food Systems e-course

Funding the Future Panel Discussion: Investments in Cell & Gene Therapies and Enabling Technologies

WIELKI MECZ LIVERPOOLU! 4 GOLE I AWANS DO ĆWIERĆFINAŁU! LIVERPOOL - GALATASARAY, SKRÓT MECZU

Jacek Bartosiak: załamanie łańcuchów dostaw i rynek leków w Europie

Pharma Forum Interview Series, Episode 2: Jeffrey Cesari, Meetings & Events Leader

PD-1-Targeted, Receptor-Masked IL-2 with Enhanced Therapeutic Window for Cancer Immunotherapy

Exploring Targeted, Non-pan-cytotoxic ADC Payloads Across Different Targets for Efficacy

Илон Маск: Оптимус 3 уже на подходе, рекурсивное самосовершенствование уже здесь, и Сингулярность...